BioMerieux Q1 Revenues Up 8 Percent Including BioFire Sales Contribution | GenomeWeb

NEW YORK (GenomeWeb) — BioMérieux today reported a 3 percent increase in first quarter revenues year over year, but an 8 percent increase when including sales from recent acquisition BioFire Diagnostics and at constant exchange rates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.